Abstract
Biomarkers may be helpful in prediction of outcomes of infants with congenital diaphragmatic hernia. The predictive value of high-sensitivity troponin T and N-terminal pro-brain natriuretic peptide was investigated in 128 infants with congenital diaphragmatic hernia. After correction for multiple testing, those biomarkers did not predict severe pulmonary hypertension, death, need of extracorporeal membrane oxygenation, or bronchopulmonary dysplasia. Trial registration Netherlands Trial Registry: 1310.
Original language | English |
---|---|
Journal | Journal of pediatrics |
Early online date | 11 Apr 2016 |
DOIs | |
Publication status | E-pub ahead of print - 11 Apr 2016 |
Keywords
- Biomarkers
- pulmonary hypertension